TCTMD

Paclitaxel-Eluting Balloon Results in High Patency Rate at 1 Year in Below-the-Knee Lesions

MIAMI BEACH, FLA.—In patients with critical limb ischemia or life-limiting claudication, use of a drug-eluting balloon to treat below-the-knee arterial lesions is safe, feasible and produces favorable ...
TCTMD

Drug-Eluting Balloon Fails for Below-the-Knee Lesions in Critical Limb Ischemia Patients

In patients with critical limb ischemia (CLI), below-the-knee revascularization with a drug-eluting balloon (DEB) is as effective as standard balloon angioplasty, although DEB use is linked with a ...
Business Insider

Enrolment initiated in World's First RCT with Sirolimus Coated Balloon for the treatment of Below-the-Knee (BTK) Peripheral Artery Disease

SINGAPORE, Aug. 27, 2020 /PRNewswire/ -- Concept Medical Inc., focused on vascular intervention drug delivery devices, has announced the enrolment of the first patient in the FUTURE BTK trial ...
Business Insider

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease

First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease Follows Breakthrough Device designation for Virtue ...